Applied Dna Sciences (APDN) EBITDA (2005 - 2025)
Applied Dna Sciences (APDN) EBITDA from Jun 30, 2005 to Jun 30, 2025. The TTM Applied Dna Sciences (APDN) EBITDA is -$13M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Applied Dna Sciences (APDN) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -9.04% |
| 3 Years TTM | +5.36% |
| 5 Years TTM | +5.51% |
| 10 Years TTM | +3.06% |
| All Time TTM | -3.19% |
Annual EBITDA change of Applied Dna Sciences (APDN)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$7.08M | -46.89% |
| 2024 | -$13M | +39.00% |
| 2023 | -$9.59M | -24.37% |
| 2022 | -$13M | +8.56% |
| 2021 | -$12M | -4.65% |
| 2020 | -$12M | +51.99% |
| 2019 | -$8.06M | -27.39% |
| 2018 | -$11M | -6.96% |
| 2017 | -$12M | +3.83% |
| 2016 | -$11M | +56.11% |
| 2015 | -$7.36M | -37.79% |
| 2014 | -$12M | +20.10% |
| 2013 | -$9.85M | +59.13% |
| 2012 | -$6.19M | -19.51% |
| 2011 | -$7.69M | +13.93% |
| 2010 | -$6.75M | -221.62% |
| 2009 | $5.55M | -249.19% |
| 2008 | -$3.72M | -65.30% |
| 2007 | -$11M | -25.24% |
| 2006 | -$14M | -58.41% |
| 2005 | -$34M | N/A |